Webinar Recording: Mar 3, 2021 9AM — 10 am (ET) / 3 pm — 4 pm (CET)
Calculating Risk and Return in Oncology Development
In this session, we investigate macro trends and forecasts in oncology using proprietary EvaluatePharma and Evaluate Omnium metrics, and offer perspectives from our work on the best frameworks and methodologies to quantify risk and return in highly dynamic oncology markets.
This live session will be animated by:
- Dr. Paul Verdin, Head of Custom Solutions at Evaluate
- Henry Barling, Senior Oncology Analyst at Evaluate